Filtered By:
Source: International Journal of Cardiology
This page shows you your search results in order of date.
Order by Relevance | Date
Total 880 results found since Jan 2013.
ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NA ÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
We assessed the cumulative incidence of recurrent stroke, major bleeding and all-cause mortality associated with restarting antithrombotic treatment, in patients experiencing an anticoagulation-related event (stroke or major bleeding), occurred during anticoagulation therapy for AF.Methods and Results.We performed a retrospective population-based analysis on linked claims data of patients resident in the Veneto Region, treated with DOACs for AF and discharged (2013 −2020) from the hospital for stroke, intracranial haemorrhage (ICH), and major bleeding.
Source: International Journal of Cardiology - September 16, 2023 Category: Cardiology Authors: N. Gennaro, E. Ferroni, M. Zorzi, G. Denas, V. Pengo Source Type: research
Heightened risk of ischemic stroke and mortality in takotsubo syndrome: A function of what?
To the Editor:
Source: International Journal of Cardiology - September 6, 2023 Category: Cardiology Authors: John E. Madias Tags: Letter to the Editor Source Type: research
Intracranial haemorrhage in acute myocardial infarction: A rare but dramatic complication
The shift from thrombolysis to primary percutaneous coronary intervention (PCI) and the use of multidrug antithrombotic therapy in the management of acute myocardial infarction (AMI) have led to both a substantial improvement in outcomes and a reduction in bleeding complications [1,2]. In particular, in AMI, the rate of haemorrhagic stroke, the most dreaded haemorrhagic complication, decreased by 50% from 1998 to 2008 [1]. Despite its low incidence, intracranial haemorrhage (ICH) is often devastating, being associated with severe disability and high mortality rates.
Source: International Journal of Cardiology - August 29, 2023 Category: Cardiology Authors: Filippo Trombara, Nicola Cosentino, Giancarlo Marenzi Tags: Editorial Source Type: research
Takotsubo syndrome and stroke risk: A nationwide register-based study
Previous small-scale studies have indicated a short-term stroke incidence of 1.0 –1.3% following Takotsubo (syndrome). In this nationwide register-based study, we investigated the 90-day risk of ischemic stroke (IS) or transient ischemia attack (TIA) and mortality of patients with Takotsubo.
Source: International Journal of Cardiology - August 22, 2023 Category: Cardiology Authors: Nicolai Jessen, Jens Aamann Andersen, Bhupendar Tayal, Lauge Østergaard, Mikkel Porsborg Andersen, Morten Schmidt, Emil Loldrup Fosbøl, Morten Schou, Peter Søgaard, Gunnar Gislason, Christian Torp-Pedersen, Lars Køber, Kristian Kragholm Source Type: research
Detection rates of asymptomatic carotid artery stenosis and atrial fibrillation by selective screening of patients without cardiovascular disease
Individuals with significant asymptomatic carotid artery stenosis (ACAS) and atrial fibrillation (AF) could benefit from specific interventions to prevent heart attack and stroke, but are often clinically ‘silent’. We aimed to determine detection rate of ACAS and AF by screening, targeting a population at increased cardiovascular risk.
Source: International Journal of Cardiology - August 10, 2023 Category: Cardiology Authors: Michiel H.F. Poorthuis, Paul Sherliker, Gert J. de Borst, Rachel Clack, Sarah Lewington, Robert Clarke, Richard Bulbulia, Alison Halliday Source Type: research
Detection rates of asymptomatic carotid stenosis and atrial fibrillation by selective screening of patients without cardiovascular disease
Individuals with significant asymptomatic carotid stenosis (ACAS) and atrial fibrillation (AF) could benefit from specific interventions to prevent heart attack and stroke, but are often clinically ‘silent’. We aimed to determine detection rate of ACAS and AF by screening targeting a population at increased cardiovascular risk.
Source: International Journal of Cardiology - August 10, 2023 Category: Cardiology Authors: Michiel H.F. Poorthuis, Paul Sherliker, Gert J. de Borst, Rachel Clack, Sarah Lewington, Robert Clarke, Richard Bulbulia, Alison Halliday Source Type: research
Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source
Left atrial myopathy has been implicated in atrial fibrillation (AF)-related stroke and embolic stroke of undetermined source (ESUS).
Source: International Journal of Cardiology - July 25, 2023 Category: Cardiology Authors: Stavroula Papapostolou, John Kearns, Benedict T. Costello, Jessica O'Brien, Murray Rudman, Mark C. Thompson, Geoffrey Cloud, Dion Stub, Andrew J. Taylor Source Type: research
Risk of cardioembolic ischemic events and relation to atrial fibrillation/flutter in patients with arrhythmogenic cardiomyopathy during a long-term follow-up
This study sought to determine the occurrence of cardioembolic ischemic events (CIEs) in ACM patients and to identify clinical and imaging predictors of CIEs.
Source: International Journal of Cardiology - July 21, 2023 Category: Cardiology Authors: Elisabetta Toso, Francesca De Lio, Pier Paolo Bocchino, Claudia Raineri, Francesco Fioravanti, Elena Maria Richiardi, Gianluca Marcelli, Tania Sacco, Carla Giustetto, Fiorenzo Gaita Source Type: research
Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with hypertrophic obstructive cardiomyopathy (HOCM), with an estimated prevalence of approximately 20% [1]. AF is associated with malignant outcomes in patients with HOCM, with an increased risk of embolic stroke, heart failure, severe functional impairment and mortality [2]. Furthermore, AF is poorly tolerated by patients with HOCM, with increased heart failure episodes, hemodynamic instability and impaired quality of life [3].
Source: International Journal of Cardiology - July 8, 2023 Category: Cardiology Authors: Alessandra Sala, Ottavio Alfieri Tags: Editorial Source Type: research
The real world of stroke incidence in patients with hypertrophic cardiomyopathy
We have read a paper with great interest written by Fumagalli and colleagues concerning “the incidence of stroke in patients with hypertrophic cardiomyopathy (HCM) among different heart rhythm” [1]. In this paper, the authors found that stroke rates in HCM patients no prior history of atrial fibrillation (AF), stroke rates were similar in those with de novo AF or stable sinus rate (SR). And they further observed that severe left atrium dilatation was a powerful risk factor, irrespective of AF. The results provided evidence for the anticoagulation strategies to prevent stroke in patients with HCM.
Source: International Journal of Cardiology - July 7, 2023 Category: Cardiology Authors: Xinru Chen Tags: Letter to the Editor Source Type: research
Patent foramen ovale closure with the Occlutech Figulla flex II device: A long-term (up to 10-years) follow-up
Percutaneous closure represents the first line of treatment In patients with cryptogenic stroke and documented patent foramen ovale (PFO). Scarce data report the long-term outcomes of patients undergoing PFO closure with the Figulla Flex II device (Occlutech, Germany).
Source: International Journal of Cardiology - June 8, 2023 Category: Cardiology Authors: Daniela Trabattoni, Sebastiano Gili, Giuseppe Calligaris, Giovanni Teruzzi, Sarah Troiano, Paolo Ravagnani, Giulia Santagostino Baldi, Piero Montorsi Source Type: research
Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation
We aimed to assess the prevalence of prior anticoagulation therapy (warfarin or non-vitamin K antagonist oral anticoagulants [NOACs]) among patients with acute ischemic stroke (AIS) and atrial fibrillation (AF) in China and investigate the associations between prior anticoagulation therapy and initial stroke severity and in-hospital outcomes.
Source: International Journal of Cardiology - May 29, 2023 Category: Cardiology Authors: Lue Zhou, Yapeng Li, Xin Yang, Hongqiu Gu, Yanran Duan, Hang Fu, Anran Wang, Kai Liu, Yuan Gao, Bo Song, Yusheng Li, Yingyu Jiang, Jing Zhang, Chunjuan Wang, Meng Wang, Zixiao Li, Yuming Xu, Chengzeng Wang, Yongjun Wang Source Type: research
Stroke in hypertrophic cardiomyopathy. Never mind the rhythm
“Il core à quattro ventriculi, cioè due inferiori e nella sustanza del core e due superiori for della sustanza del core, … e li superiori son separati da certi uscioli (ovver porte del core) dalli ventricoli inferiori”.“The heart has four ventricles, that is two lower in the substance of t he heart, and two upper outside the substance of the heart, ... and the upper ones are separated by little doors from the lower ventricles”.Leonardo da Vinci, The Royal collection, Windsor, UK.
Source: International Journal of Cardiology - May 25, 2023 Category: Cardiology Authors: Maurizio Pieroni, Michele Ciabatti, Leonardo Bolognese Tags: Editorial Source Type: research
Global, regional, and national time trends in mortality for stroke, 1990 –2019: An age-period-cohort analysis for the global burden of disease 2019 study and implications for stroke prevention
Notwithstanding mortality from stroke has increased globally over the past 30 years, adverse period and cohort effects have been found in many countries, calling into question the adequacy of healthcare for stroke patients of all ages. These lapses have a significant impact on the likelihood of achieving the Sustainable Development Goal (SDG) targets on mortality from age 60+ and NCDs.
Source: International Journal of Cardiology - May 5, 2023 Category: Cardiology Authors: Shengxian Peng, Xiaozhu Liu, Wenzhai Cao, Yue Liu, Yuan Liu, Wei Wang, Ting Zhang, Xiaoyan Guan, Juan Tang, Qingwei Zhang Source Type: research
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring
Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of stroke, but the incidence and factors associated with cardioembolic events in HCM patients without atrial fibrillation (AF) remain unresolved. We determined the incidence of stroke in patients in sinus rhythm (SR) monitored with a cardiac implantable electronic device (CIED).
Source: International Journal of Cardiology - April 13, 2023 Category: Cardiology Authors: Carlo Fumagalli, Francesca Bonanni, Matteo Beltrami, Roberta Ruggieri, Chiara Zocchi, Luigi Tassetti, Niccol ò Maurizi, Martina Berteotti, Mattia Zampieri, Alessia Argirò, Fabrizio Lovero, Alessia Tomberli, Mauro di Bari, Niccolò Marchionni, Paolo Pier Source Type: research
